![[Featured Stock] Remedi surges over 30% in early trading on first day of KOSDAQ listing](/api/img?u=https%3A%2F%2Fwww.chosun.com%2Fresizer%2Fv2%2FGQ4DEMRUHEZGCNBZMYYTENRVMU.jpg%3Fauth%3D8aee17f4032a27deb6c80189c702df7fc83c460b007db71e5c264e1b2cd4b4c3%26smart%3Dtrue%26width%3D2325%26height%3D690&w=1200)
[Featured Stock] Remedi surges over 30% in early trading on first day of KOSDAQ listing
It also attracted investments from LG Electronics and Nanox, a US Nasdaq-listed company, through a rights offering in 2022.
- Right1
- Agency1
no rewrites detected — all voices distinct
Summary
It also attracted investments from LG Electronics [066570] and Nanox, a US Nasdaq-listed company, through a rights offering in 2022. Remedi, a company specializing in radiation X-ray technology, is showing strength on its first day of listing on the KOSDAQ market, with its stock price rising more than 30% above the IPO price in early trading.
Cross-referenced from 2 sources.
Factual coreconfirmed by several independent voices
Insufficient core: not enough independent confirmations to retain a shared fact.
Reported detailssecondary facts, each attributed to its source
It also attracted investments from LG Electronics [066570] and Nanox, a US Nasdaq-listed company, through a rights offering in 2022.
according to Yonhap News AgencyRemedi, a company specializing in radiation X-ray technology, is showing strength on its first day of listing on the KOSDAQ market, with its stock price rising more than 30% above the IPO price in early trading.
according to Chosun Ilbo
Disputedincompatible versions — to verify
No factual contradiction detected between sources.
Framing by sidesame fact, different words — loaded terms highlighted
No notable framing divergence.
Blind spotwhat one side keeps silent
No blind spot detected: every side covers the same facts.
Sources2 sources cross-checked
Right1
Agency1
